New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonists.
Yea CM, Allan CE, Ashworth DM, Barnett J, Baxter AJ, Broadbridge JD, Franklin RJ, Hampton SL, Hudson P, Horton JA, Jenkins PD, Penson AM, Pitt GR, Rivière P, Robson PA, Rooker DP, Semple G, Sheppard A, Haigh RM, Roe MB.
Yea CM, et al.
J Med Chem. 2008 Dec 25;51(24):8124-34. doi: 10.1021/jm8008162.
J Med Chem. 2008.
PMID: 19053774
We report herein the discovery of potent, nonpeptidic, benzylurea derived agonists of the vasopressin V2 receptor. We describe substitutions on the benzyl group to give improvements in potency and subsequent modifications to the urea end group to provide improvements in so …
We report herein the discovery of potent, nonpeptidic, benzylurea derived agonists of the vasopressin V2 receptor. We describe substi …